New hope for adult leukemia patients in Early-Stage drug trial
NCT ID NCT05157971
Summary
This early-stage study is testing whether adding a drug called venetoclax to a standard, intensive chemotherapy regimen is safe and tolerable for adults newly diagnosed with a type of B-cell acute lymphoblastic leukemia (ALL). The goal is to find the best dose of venetoclax to use with the chemotherapy and see if the combination helps control the cancer. The study will enroll up to 24 adults aged 18-54 who have not yet received treatment for their leukemia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.